|
|
|
|
|
| |
|
|
International Clinical Trials
|
|
|
ICT is a specialist journal designed to provide global coverage of key topics pertinent
to the clinical trials sector.
|
|
| |
|
|
| |
|
|
European Biopharmaceutical Review
|
|
|
|
EBR is well-recognised for providing beneficial information to players in the bio-industry including entrepreneurial biopharmaceutical and life science companies
|
|
|
|
|
Website design and development by Rubler Studio
|
|
|
.
 |
News and Press Releases |
 |
"Genome Editing of Immune Cells" - New Lonza Virtual Event
Basel, Switzerland, 06 September 2022 – On September 20, 2022,
Lonza will host a free virtual workshop on using genome editing
technologies for cell and gene therapies and drug discovery. The 3-hour
workshop brings together renowned genome editing experts from across
industry and academia and comprises four interactive speaker sessions
and a concluding panel discussion. The event is a chance for researchers
to engage directly with leading voices in the field, keep up to date
with the latest CRISPR research and application, and discover tips and
tricks for optimized CRISPR editing and screening.
More info >> |
|
.
 |
White Papers |
 |
|
7 Common Myths about QP Training Debunked: A Guide for Senior Managers
RSSL
The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >> |
|
|
|
